Analysis of pulmonary function test and medication treatment of patients with chronic obstructive pulmonary disease aged 40 years or older in community of Guangdong Province_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

SONG Xinrui ¹ , LI Zhanglong ¹ , LI Chuan ² , MENG Ruilin ² , XU Yanjun ² , ZHENG Xueyan ² , XIAO Ni ² ,  LI Lixia ¹

1. School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510310, P. R. China;
2. Institute of Non-Communicable Disease Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou, Guangdong, 511430, P. R. China;

Corresponding?author：

LI Lixia, Email: llx19@163.com

Keywords：

Chronic obstructive pulmonary disease; Pulmonary function test; Medication treatment; Influencing factors

DOI：

10.7507/1671-6205.202204072

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the rate of pulmonary function test, medication treatment, and relevant factors among patients with chronic obstructive pulmonary disease (COPD) aged 40 years or older in community of Guangdong Province, and to provide evidences for targeted intervention of COPD. Methods A multistage stratified cluster sampling was conducted in the community residents, who participated in the COPD surveillance project of in Guangdong Province during 2019 to 2020. A total of 3384 adults completed questionnaire and pulmonary function test. The Rao-Scott χ² test based on complex sampling design, and non-conditional Logistic regression were used to explore possible influencing factors of pulmonary function test and medication treatment in COPD patients. Results Out of the 3384 adults, 288 patients with COPD were confirmed, including 253 males (87.8%) and 35 females (12.2%), and 184 patients (60.4%) were over 60 years old or more. The pulmonary function test rate was 10.7% [95% confidence interval (CI) 6.8% - 14.6%], and medication treatment rate was 10.6% (95%CI 7.0% - 14.1%). The results showed that wheezing, awareness of COPD related knowledge and pulmonary function test were related to whether COPD patients had pulmonary function test (P<0.05). Wheezing and personal history of respiratory diseases were related to medication treatment rate (P<0.05). Conclusions The rates of pulmonary function test and medication treatment among COPD patients aged 40 years or older are low. Health education about COPD should be actively carried out, and the screening of individuals with a history of respiratory diseases and respiratory symptoms should be strengthened so as to reduce the burden of COPD diseases.

Citation： SONG Xinrui, LI Zhanglong, LI Chuan, MENG Ruilin, XU Yanjun, ZHENG Xueyan, XIAO Ni, LI Lixia. Analysis of pulmonary function test and medication treatment of patients with chronic obstructive pulmonary disease aged 40 years or older in community of Guangdong Province. Chinese Journal of Respiratory and Critical Care Medicine, 2022, 21(5): 309-315. doi: 10.7507/1671-6205.202204072 Copy

1.	Fang LW, Gao P, Bao HL, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med, 2018, 6(6): 421-430.
2.	Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
3.	The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease 2022 Report [EB/OL]. (2021-11-15)[2022-03-22].https://goldcopd.org/2022-gold-reports/.
4.	呂學莉, 叢舒, 樊靜, 等. 2014—2015年中國40歲及以上慢性阻塞性肺疾病患者肺功能檢查率及其影響因素分析. 中華流行病學雜志, 2020, 41(5): 672-677.
5.	張陽, 王寧, 樊靜, 等. 2014—2015年中國40歲及以上慢性阻塞性肺疾病患者藥物治療率及其影響因素分析. 中華流行病學雜志, 2020, 41(5): 678-684.
6.	李婧辰, 張梅, 李鎰沖, 等. 我國40歲及以上人群慢性呼吸系統疾病癥狀流行現況及影響因素研究. 中華流行病學雜志, 2018, 39(6): 786-791.
7.	Zheng XY, Li ZL, Li C, et al. Effects of cigarette smoking and biomass fuel on lung function and respiratory symptoms in middle-aged adults and the elderly in Guangdong province, China: a cross-sectional study. Indoor Air, 2020, 30(5): 860-871.
8.	Devien L, Giovannelli J, Cuny D, et al. Sources of household air pollution: the association with lung function and respiratory symptoms in middle-aged adult. Environ Res, 2018, 164: 140-148.
9.	王凱棣. 老年慢性阻塞性肺疾病患者CAT評分與BODE指數的相關性研究[D]. 華北理工大學, 2018.
10.	方利文, 包鶴齡, 王寶華, 等. 2014年中國40歲及以上人群肺功能檢查率調查與分析. 中華流行病學雜志, 2018, 39(5): 593-599.
11.	叢舒, 馮雅靖, 包鶴齡, 等. 2014年中國40歲及以上人群二手煙暴露狀況分析. 中華流行病學雜志, 2018, 39(5): 557-562.
12.	包鶴齡, 叢舒, 王寧, 等. 2014年中國慢性阻塞性肺疾病高危人群現狀調查與分析. 中華流行病學雜志, 2018, 39(5): 580-585.
13.	樊靜, 王寧, 方利文, 等. 2014年中國40歲及以上人群慢性阻塞性肺疾病知識知曉率及其影響因素. 中華流行病學雜志, 2018, 39(5): 586-592.
14.	李杉, 賈存波, 方方, 等. 我國18地區醫療機構醫生慢性阻塞性肺疾病知識認知調查研究. 中國健康教育, 2020, 36(3): 195-199.
15.	陳婧瑜, 鐘文玲, 朱瑤, 等. 福建省40歲以上居民肺功能檢查抽樣調查. 預防醫學論壇, 2019, 25(3): 210-212.
16.	查震球, 何玉琢, 徐偉, 等. 安徽省居民慢性阻塞性肺疾病診斷和防控狀況分析. 中國公共衛生, 2021, 37(2): 290-292.
17.	邵英, 楊永芳, 秦明芳, 等. 云南省40歲及以上居民肺功能檢查率及影響因素分析. 中國慢性病預防與控制, 2019, 27(10): 739-743.
18.	李章龍. 廣東省社區COPD患者知識知曉、檢查、治療狀況及COPD診斷模型[D]. 廣東藥科大學, 2021.
19.	國務院辦公廳. 中國防治慢性病中長期規劃(2017—2025年)[EB/OL]. (2017-01-22)[2021-09-25]. http://www.gov.cn/zhengce/content/2017-02/14/content-516788.
20.	國務院辦公廳. 健康中國行動(2019—2030年)[EB/OL]. (2019-07-15)[2022-03-28]. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.
21.	吳仲平, 鄭勁平, 沈北蘭, 等. 廣東省肺功能檢查應用現狀調查與分析. 中國全科醫學, 2021, 24(23): 2950-2954.

1. Fang LW, Gao P, Bao HL, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med, 2018, 6(6): 421-430.
2. Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
3. The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease 2022 Report [EB/OL]. (2021-11-15)[2022-03-22].https://goldcopd.org/2022-gold-reports/.
4. 呂學莉, 叢舒, 樊靜, 等. 2014—2015年中國40歲及以上慢性阻塞性肺疾病患者肺功能檢查率及其影響因素分析. 中華流行病學雜志, 2020, 41(5): 672-677.
5. 張陽, 王寧, 樊靜, 等. 2014—2015年中國40歲及以上慢性阻塞性肺疾病患者藥物治療率及其影響因素分析. 中華流行病學雜志, 2020, 41(5): 678-684.
6. 李婧辰, 張梅, 李鎰沖, 等. 我國40歲及以上人群慢性呼吸系統疾病癥狀流行現況及影響因素研究. 中華流行病學雜志, 2018, 39(6): 786-791.
7. Zheng XY, Li ZL, Li C, et al. Effects of cigarette smoking and biomass fuel on lung function and respiratory symptoms in middle-aged adults and the elderly in Guangdong province, China: a cross-sectional study. Indoor Air, 2020, 30(5): 860-871.
8. Devien L, Giovannelli J, Cuny D, et al. Sources of household air pollution: the association with lung function and respiratory symptoms in middle-aged adult. Environ Res, 2018, 164: 140-148.
9. 王凱棣. 老年慢性阻塞性肺疾病患者CAT評分與BODE指數的相關性研究[D]. 華北理工大學, 2018.
10. 方利文, 包鶴齡, 王寶華, 等. 2014年中國40歲及以上人群肺功能檢查率調查與分析. 中華流行病學雜志, 2018, 39(5): 593-599.
11. 叢舒, 馮雅靖, 包鶴齡, 等. 2014年中國40歲及以上人群二手煙暴露狀況分析. 中華流行病學雜志, 2018, 39(5): 557-562.
12. 包鶴齡, 叢舒, 王寧, 等. 2014年中國慢性阻塞性肺疾病高危人群現狀調查與分析. 中華流行病學雜志, 2018, 39(5): 580-585.
13. 樊靜, 王寧, 方利文, 等. 2014年中國40歲及以上人群慢性阻塞性肺疾病知識知曉率及其影響因素. 中華流行病學雜志, 2018, 39(5): 586-592.
14. 李杉, 賈存波, 方方, 等. 我國18地區醫療機構醫生慢性阻塞性肺疾病知識認知調查研究. 中國健康教育, 2020, 36(3): 195-199.
15. 陳婧瑜, 鐘文玲, 朱瑤, 等. 福建省40歲以上居民肺功能檢查抽樣調查. 預防醫學論壇, 2019, 25(3): 210-212.
16. 查震球, 何玉琢, 徐偉, 等. 安徽省居民慢性阻塞性肺疾病診斷和防控狀況分析. 中國公共衛生, 2021, 37(2): 290-292.
17. 邵英, 楊永芳, 秦明芳, 等. 云南省40歲及以上居民肺功能檢查率及影響因素分析. 中國慢性病預防與控制, 2019, 27(10): 739-743.
18. 李章龍. 廣東省社區COPD患者知識知曉、檢查、治療狀況及COPD診斷模型[D]. 廣東藥科大學, 2021.
19. 國務院辦公廳. 中國防治慢性病中長期規劃(2017—2025年)[EB/OL]. (2017-01-22)[2021-09-25]. http://www.gov.cn/zhengce/content/2017-02/14/content-516788.
20. 國務院辦公廳. 健康中國行動(2019—2030年)[EB/OL]. (2019-07-15)[2022-03-28]. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.
21. 吳仲平, 鄭勁平, 沈北蘭, 等. 廣東省肺功能檢查應用現狀調查與分析. 中國全科醫學, 2021, 24(23): 2950-2954.

Chinese Journal of Respiratory and Critical Care Medicine

Analysis of pulmonary function test and medication treatment of patients with chronic obstructive pulmonary disease aged 40 years or older in community of Guangdong Province

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content